| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/16/1992 | WO1992014488A1 Structural gene of pneumococcal protein |
| 08/12/1992 | EP0497922A1 Infective protein delivery system |
| 08/12/1992 | EP0497875A1 2' modified oligonucleotides |
| 08/11/1992 | US5138045 Polyamine conjugated oligonucleotides |
| 08/06/1992 | WO1992012996A2 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 08/06/1992 | WO1992012725A1 Treatment of neoplastic disease with interleukin-10 |
| 08/06/1992 | CA2101065A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 08/06/1992 | CA2100553A1 Treatment of neoplastic disease with interleukin-10 |
| 08/05/1992 | EP0496769A1 Extracellular matrix protein adherent t cells |
| 08/04/1992 | US5135916 Inhibition of complement mediated inflammatory response |
| 07/23/1992 | WO1992012242A1 Modified hepatocytes and uses therefor |
| 07/23/1992 | WO1992011896A1 Drug delivery system |
| 07/23/1992 | WO1992005266A3 Packaging cells |
| 07/23/1992 | CA2076848A1 Modified hepatocytes and uses therefor |
| 07/22/1992 | EP0451206A4 Receptor transcription-repression activity compositions and methods |
| 07/15/1992 | EP0494776A1 Method of altering the metabolic state of non-dividing cells and obtained transgenic animals |
| 07/15/1992 | EP0494244A1 Therapeutic ribozyme compositions and expression vectors |
| 07/09/1992 | WO1992011359A1 A truncated interleukin-1 receptor gene for the treatment of arthritis |
| 07/09/1992 | WO1992011355A1 Method for culturing and transforming human stem cell-containing compositions |
| 07/09/1992 | WO1992011033A1 Control of gene expression by ionizing radiation |
| 07/09/1992 | CA2098848A1 Truncated interleukin-1 receptor gene for the treatment of arthritis |
| 07/08/1992 | EP0448704A4 Osteogenic devices |
| 07/05/1992 | WO1992011874A1 Tumor susceptible non-human animals |
| 07/05/1992 | CA2098827A1 Tumor susceptible non-human animals |
| 06/25/1992 | WO1992010573A1 Methods and compositions for the suppression of neu mediated transformation |
| 06/25/1992 | WO1992010568A1 Dna which codes for neurotrophic activity inhibitor and use thereof |
| 06/25/1992 | WO1992010563A1 Immortalized cell lines and applications thereof, especially for the production of differentiated cells |
| 06/25/1992 | CA2077350A1 Dna coding for growth-inhibitory factor and use thereof |
| 06/17/1992 | EP0490077A1 Antisense oligonucleotides for treatment of cancer |
| 06/17/1992 | EP0489830A1 Expression of alpha-macroglobulins |
| 06/16/1992 | US5122517 Antiviral combination comprising nucleoside analogs |
| 06/15/1992 | WO1992010506A1 Human retrovirus receptor and dna coding therefor |
| 06/15/1992 | CA2097705A1 Human retrovirus receptor and dna coding therefor |
| 06/14/1992 | WO1992010564A1 Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy |
| 06/14/1992 | CA2098510A1 Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy |
| 06/11/1992 | WO1992009688A1 MICE HAVING β2 MICROGLOBULIN GENE DISRUPTION |
| 06/11/1992 | WO1992002534A3 Compounds and methods for inhibiting gene expression |
| 06/10/1992 | EP0489058A1 Cystic fibrosis gene |
| 06/04/1992 | WO1992009616A1 Enhancement of musculature in animals |
| 06/04/1992 | CA2097590A1 Enhancement of musculature in animals |
| 06/03/1992 | EP0487587A1 Recombinant retroviruses delivering vector constructs to target cells |
| 05/26/1992 | US5116964 Hybrid immunoglobulins |
| 05/14/1992 | WO1992008796A1 Bifunctional selectable fusion genes |
| 05/14/1992 | WO1992007945A1 Cell type specific alteration of levels of gene products in neural cells |
| 05/14/1992 | WO1992007943A1 Retroviral vectors useful for gene therapy |
| 05/14/1992 | WO1992007939A2 Polypeptide with 46kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | WO1992007573A1 Genetic modification of endothelial cells |
| 05/14/1992 | WO1992007572A1 Agents and methods for binding to elam-1 |
| 05/14/1992 | CA2095330A1 Polypeptide with kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | CA2095256A1 Retroviral vectors useful for gene therapy |
| 05/14/1992 | CA2094911A1 Agents and methods for binding to elam-1 |
| 05/08/1992 | WO1992008456A2 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 05/08/1992 | CA2095732A1 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 05/06/1992 | WO1992007580A1 Therapeutic uses of melanin |
| 05/06/1992 | EP0483219A1 Enhancement of musculature in animals |
| 05/03/1992 | CA2488792A1 Antisense oligonucleotides for treatment of cancer |
| 04/30/1992 | WO1992007071A1 Methods and applications for efficient genetic suppressor elements |
| 04/30/1992 | WO1992007065A1 Modified ribozymes |
| 04/30/1992 | WO1992007000A1 Pharmaceutical composition for the treatment or prevention of a malignant tumor |
| 04/30/1992 | WO1992006702A1 A method for transplanting cells into the brain and therapeutic uses therefor |
| 04/30/1992 | CA2423998A1 Methods and applications for efficient genetic suppressor elements |
| 04/28/1992 | US5109124 Nucleic acid probe linked to a label having a terminal cysteine |
| 04/23/1992 | WO1992006693A1 Dna construct for providing rna therapy |
| 04/23/1992 | CA2094608A1 Dna construct for providing rna therapy |
| 04/16/1992 | WO1992006190A1 Transgenic model for selective targeting of gene products with a megakaryocyte promoter |
| 04/15/1992 | EP0479866A1 Pestivirus nucleotide sequences and polypeptides |
| 04/10/1992 | WO1992006192A1 Inhibition of viral replication |
| 04/10/1992 | CA2093816A1 Inhibition of viral replication |
| 04/08/1992 | EP0478708A1 Formation of triple helix complexes of double stranded dna using nucleoside oligomers |
| 04/02/1992 | WO1992006180A1 Targeting viruses and cells for selective internalization by cells |
| 04/02/1992 | WO1992005262A1 Methods and compositions for genetic therapy and potentiation of anti-tumor immunity |
| 04/02/1992 | WO1992005254A1 Novel neurothrophic factor |
| 04/02/1992 | WO1992005195A1 Viral growth inhibition |
| 04/02/1992 | WO1992005184A1 A non-mitogenic competitive hgf antagonist |
| 04/02/1992 | CA2092323A1 Targeting viruses and cells for selective internalization by cells |
| 04/01/1992 | EP0477994A1 Parasite-derived resistance |
| 04/01/1992 | EP0477290A1 Methods, compositions and devices for growing cells. |
| 03/26/1992 | WO1992005250A1 Prolonging expression of polynucleotides introduced into a cell |
| 03/26/1992 | CA2092319A1 Prolonging expression of polynucleotides introduced into a cell |
| 03/25/1992 | EP0476953A2 Viral targeted destruction of neoplastic cells |
| 03/24/1992 | US5098823 Chromosome-specific nucleic acid probe for familial polyposis coli |
| 03/22/1992 | WO1992005284A1 Compositions and methods for inhibiting growth or replication of viruses |
| 03/22/1992 | WO1992005266A2 Packaging cells |
| 03/22/1992 | CA2092711A1 Compositions and methods for inhibiting growth or replication of viruses |
| 03/19/1992 | WO1992005273A1 Gene therapy for cystic fibrosis |
| 03/19/1992 | WO1992004446A1 Cloning of chicken anaemia dna |
| 03/19/1992 | WO1992004033A1 Methods for inhibiting rejection of transplanted tissue |
| 03/19/1992 | CA2289222A1 Gene therapy for cystic fibrosis |
| 03/18/1992 | WO1992005272A1 Method and composition for controlling proliferation of cells |
| 03/18/1992 | EP0475623A1 Genetic mechanisms of tumor supression |
| 03/18/1992 | EP0475178A1 Liposome for entrapping gene, liposomal preparation and process for the manufacture of the preparation |
| 03/18/1992 | EP0474979A1 Heparin binding neurotrophic factor gene sequence |
| 03/18/1992 | CA2091759A1 Method and composition for controlling proliferation of cells |
| 03/05/1992 | WO1992003568A1 Sugar modified oligonucleotides that detect and modulate gene expression |
| 03/05/1992 | WO1992003566A1 Therapeutic ribozyme compositions |
| 03/05/1992 | WO1992003545A1 Flavivirus recombinant poxvirus vaccine |
| 03/05/1992 | WO1992003537A1 Self-assembling replication defective hybrid virus particles |
| 03/05/1992 | WO1992003456A1 Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 03/05/1992 | WO1992003139A1 Oligonucleotide modulation of cell adhesion |
| 03/05/1992 | CA2089497A1 Self-assembling replication defective hybrid virus particles |